[Non-fatal drug-drug interaction between capecitabine and brivudine].

1. Rigopoulos D, Larios G, Katsambas AD. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies. Clin Dermatol 2010;28:24-30. 2. Zane LT, Leyden WA, Marqueling AL, Manos MM. A populationbased analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016-22. 3. Ficha técnica Dercutane®. Agencia Española de Medicamentos y Productos Sanitarios. www.aemps.es 4. Dicembrini I, Bardini G, Rotella CM. Association between oral isotretinoin therapy and unmasked latent immuno-mediated diabetes. Diabetes Care 2009;32:e99. 5. Timperley AC, Withnall RDJ, Rainford DJ. The development of insulindependent diabetes mellitus in a renal transplant patient receiving oral isotretinoin. Nephrol Dialysis Transplant 1996;11: 753. 6. Koistinen HA, Remitz A, Gylling H, Miettinen TA, Koivisto VA, Ebeling P. Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid. Diabetes Metab Res Rev 2001;17:391-5. 7. FEDRA-Farmacovigilancia Española Datos de Reacciones Adversas. Fecha de búsqueda: 9 de mayo de 2012. 8. Chebane L, Tavassoli N, Bagheri H, Montastruc JL; Centres Régionaux de Pharmacovigilance Français.Drug-induced hyperglycemia: a study in the French pharmacovigilance database. Therapie 2010;65:447-58.